Idarucizumab for dabigatran reversal
CV Pollack Jr, PA Reilly, J Eikelboom… - … England Journal of …, 2015 - Mass Medical Soc
Background Specific reversal agents for non–vitamin K antagonist oral anticoagulants are
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
Idarucizumab for Dabigatran Reversal
CV Pollack, PA Reilly, J Eikelboom… - New England Journal …, 2015 - research.rug.nl
BACKGROUND Specific reversal agents for non-vitamin K antagonist oral anticoagulants
are lacking. Idarucizumab, an antibody fragment, was developed to reverse the …
are lacking. Idarucizumab, an antibody fragment, was developed to reverse the …
Idarucizumab for Dabigatran Reversal.
CV Pollack Jr, PA Reilly, J Eikelboom… - The New England …, 2015 - europepmc.org
Background Specific reversal agents for non-vitamin K antagonist oral anticoagulants are
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
Idarucizumab for dabigatran reversal
CV Pollack, PA Reilly, J Eikelboom… - New England …, 2015 - scholars.northwestern.edu
Background Specific reversal agents for non-vitamin K antagonist oral anticoagulants are
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
Idarucizumab for Dabigatran Reversal
CV Pollack Jr, PA Reilly… - The New England …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Specific reversal agents for non-vitamin K antagonist oral anticoagulants are
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …
[PDF][PDF] Idarucizumab for Dabigatran Reversal
CV Pollack Jr - N Engl J Med, 2015 - emjournalclub.com
Journal Club Eastern Virginia Medical School Therapy Article Page 1 Journal Club Eastern
Virginia Medical School Therapy Article Resident Max Miller Date: 1/23/2016 CITATION …
Virginia Medical School Therapy Article Resident Max Miller Date: 1/23/2016 CITATION …
[引用][C] Idarucizumab for Dabigatran Reversal
CV Pollack Jr, PA Reilly… - New England …, 2015 - scholarlypublications …
Idarucizumab for Dabigatran Reversal | Scholarly Publications Skip to main content
Universiteit Leiden Leiden University Scholarly Publications Home Submit About Select …
Universiteit Leiden Leiden University Scholarly Publications Home Submit About Select …
[引用][C] Idarucizumab for Dabigatran Reversal
CV Pollack, PA Reilly, J Eikelboom, S Glund… - New England Journal …, 2015 - cir.nii.ac.jp